Literature DB >> 25631810

Evaluation of Ebola virus inactivation procedures for Plasmodium falciparum malaria diagnostics.

Rachel Lau1, Amanda Wang1, Ann Chong-Kit1, Filip Ralevski1, Andrea K Boggild2.   

Abstract

Plasmodium falciparum malaria is highly endemic in the three most affected countries in the current epidemic of Ebola virus disease (EVD) in West Africa. As EVD and malaria are clinically indistinguishable, both remain part of the differential diagnosis of ill travelers from returning from areas of EVD transmission. We compared the performances of a rapid diagnostic test (BinaxNOW) and real-time PCR with P. falciparum-positive specimens before and after heat and Triton X-100 inactivation, and we documented no loss of sensitivity.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25631810      PMCID： PMC4365221          DOI： 10.1128/JCM.00165-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Influence of practicable virus inactivation procedures on tests for frequently measured analytes in plasma.

Authors:  Martin Hersberger; Charly Nusbaumer; André Scholer; Verena Knöpfli; Arnold von Eckardstein
Journal:  Clin Chem       Date:  2004-05       Impact factor: 8.327

2.  Laboratory preparedness to face infectious outbreaks. Ebola and beyond.

Authors:  Giuseppe Lippi; Camilla Mattiuzzi; Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2014-12       Impact factor: 3.694

3.  Malaria deaths in visitors to Canada and in Canadian travellers: a case series.

Authors:  K C Kain; D W MacPherson; T Kelton; J S Keystone; J Mendelson; J D MacLean
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

4.  Sequence-based optimization of a quantitative real-time PCR assay for detection of Plasmodium ovale and Plasmodium malariae.

Authors:  Melissa Phuong; Rachel Lau; Filip Ralevski; Andrea K Boggild
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

5.  Effects of viral hemorrhagic fever inactivation methods on the performance of rapid diagnostic tests for Plasmodium falciparum.

Authors:  M R Loutfy; M Assmar; D C Hay Burgess; K C Kain
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

6.  Multiplexed real-time PCR assay for discrimination of Plasmodium species with improved sensitivity for mixed infections.

Authors:  Sandra E Shokoples; Momar Ndao; Kinga Kowalewska-Grochowska; Stephanie K Yanow
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948
  6 in total
  8 in total

1.  Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.

Authors:  Sophie J Smither; Simon A Weller; Amanda Phelps; Lin Eastaugh; Sarah Ngugi; Lyn M O'Brien; Jackie Steward; Steve G Lonsdale; Mark S Lever
Journal:  J Clin Microbiol       Date:  2015-07-15       Impact factor: 5.948

Review 2.  Diagnosis of Ebola Virus Disease: Past, Present, and Future.

Authors:  M Jana Broadhurst; Tim J G Brooks; Nira R Pollock
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

3.  Inactivating Zaire Ebolavirus in Whole-Blood Thin Smears Used for Malaria Diagnosis.

Authors:  Todd A. Cutts; Bradley W. M. Cook; Guillaume Poliquin; James E. Strong; Steven S Theriault
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

4.  Rapid detection of an Ebola biomarker with optical microring resonators.

Authors:  Abraham J Qavi; Krista Meserve; M Javad Aman; Hong Vu; Larry Zeitlin; John M Dye; Jeffrey W Froude; Daisy W Leung; Lan Yang; Frederick W Holtsberg; Ryan C Bailey; Gaya K Amarasinghe
Journal:  Cell Rep Methods       Date:  2022-06-08

5.  Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests.

Authors:  Maiken Worsøe Rosenstierne; Helen Karlberg; Karoline Bragstad; Gunnel Lindegren; Malin Lundahl Stoltz; Cristiano Salata; Anne-Marte Bakken Kran; Susanne Gjeruldsen Dudman; Ali Mirazimi; Anders Fomsgaard
Journal:  J Clin Microbiol       Date:  2016-07-27       Impact factor: 5.948

Review 6.  Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.

Authors:  Nancy E Cornish; Nancy L Anderson; Diego G Arambula; Matthew J Arduino; Andrew Bryan; Nancy C Burton; Bin Chen; Beverly A Dickson; Judith G Giri; Natasha K Griffith; Michael A Pentella; Reynolds M Salerno; Paramjit Sandhu; James W Snyder; Christopher A Tormey; Elizabeth A Wagar; Elizabeth G Weirich; Sheldon Campbell
Journal:  Clin Microbiol Rev       Date:  2021-06-09       Impact factor: 50.129

Review 7.  Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks.

Authors:  Barbara Bartolini; Cesare Em Gruber; Marion Koopmans; Tatjana Avšič; Sylvia Bino; Iva Christova; Roland Grunow; Roger Hewson; Gulay Korukluoglu; Cinthia Menel Lemos; Ali Mirazimi; Anna Papa; Maria Paz Sanchez-Seco; Aisha V Sauer; Hervè Zeller; Carla Nisii; Maria Rosaria Capobianchi; Giuseppe Ippolito; Chantal B Reusken; Antonino Di Caro
Journal:  Euro Surveill       Date:  2019-01

8.  Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections.

Authors:  M M Remy; M Alfter; M-N Chiem; M T Barbani; O B Engler; F Suter-Riniker
Journal:  Clin Microbiol Infect       Date:  2018-10-28       Impact factor: 8.067
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.